Previously, it was well established that a etmycolic acid -arabinogalactan -peptidoglycan (mucopeptide)" complex is the principle structure of the cell wall ofMycobacterium as well as of Nocardia and Corynebacterium. We have also reported that the mycobacterial cell wall is the adjuvant-active fraction, having the ability to induce delayed-type hypersensitivity and enhance circulating-antibody formation in the immune response, and that the peptidoglycan moiety is the adjuvant-active unit in the chemical structure of the cell walls of mycobacteria, nocardia, and corynebacteria (2, 3, 28) . More recently, we clearly demonstrated that the cell wall of Mycobacterium bovis BCG (BCG-CWS) acts on thymus-derived lymphocytes (T cells) and bone marrow-derived lymphocytes (B cells) as adjuvant (2, (27) (28) and as mitogen (I. Azuma, T. Taniyama, K. Sugimura, and Y. Yamamura, Jpn. J. Microbiol., in press). It was also shown that BCG-CWS suppressed tumor growth when tumor cells and BCG-CWS that were treated as an oil-in-water emulsion were mixed and injected intradermally in syngeneic mice and that they induced specific and systemic tumor immunity in mice (7; Y. Yamamura, I. Azuma, T. Taniyama, K. Sugimura, F. Hirao, R. Tokuzen, M. Okabe, W. Nakahara, K. Yasumoto, and M. Ohto, Ann. N. Y. Acad. Sci., in press). The recent data suggest that the cell walls not only of Mycobacterium but also of other bacteria such as Nocardia, Corynebacterium, Streptococcus, Staphylococcus, Bacillus, Escherichia, Neisseria, Moraxella, Proteus, and anaerobic coryneforms are active as adjuvant for the induction of delayedtype hypersensitivity and circulating antibody in guinea pigs (2, 6, 10-12, 14, 22) . Recently, it was shown that N-acetylmuramyldipeptide, MurNAc-L-Ala-D-isoGln, is the simplest adjuvant-active unit of these cell wall peptidoglycans for the induction of both circulating antibody and delayed-type hypersensitivity in guinea pigs (1, 5, 13, 16, 17) . More recently, 6-O-stearoyl-N-acetylmuramyldipeptide ( Fig. 1) was prepared by the acylation of the primary hydroxy group of muramic acid of N-acetylmuramyldipeptide to ex,rnine the effect of introducing the hydrophobit group (stearoyl residue) into hydrophilic adjuvant (N-acetylmuramyldipeptide) on its immunological activity. The present paper deals with the adjuvant activity of synthetic peptides, such as tetrapeptide, N-acetylmuramyldipeptide, and 6-0-ste- aroyl-N-acetylmuramyldipeptide, in the induction of delayed hypersensitivity to monoazobenzenearsonate-N-acetyl-L-tyrosine (ABA-N-acetyltyrosine) in guinea pigs and in the production of circulating antibody to bacterial a-amylase (BaA) in mice and to the T-independent antigen DNP-Ficoll. We also report the adjuvant activity of these synthetic compounds on the generation of allogeneic cell-mediated cytotoxic effector cells in mice. The mitogenic activity of these synthetic peptides in the spleen cells of mice is examined.
MATERIALS AND METHODS
Synthetic peptides and adjuvant. The syntheses and properties of the peptides and N-acetylmuramylpeptides used in this study were described previously (18). 6-0 -stearoyl-N-acetylmuramyl-Lalanyl-D:isoglutamine (6-0-stearoyl-N-acetylmuramyldipeptide) was prepared by coupling 1-a-0-benzyl-6-0-stearoyl-N-acetylmuramic acid with Lalanyl-D-isoglutamine benzyl ester, using the 1-succinimidyl ester method followed by hydrogenolytic deprotection with palladium black catalyst.
ter, respectively, using ethyl chloroformate followed by hydrogenolytic deprotection. Details of the synthesis and chemical properties of 6-0-stearoyl-Nacetylmuramyldipeptide, i-lactyltetrapeptide, and D-lactyldipeptide will be published elsewhere. The cell wall of M. bovis BCG (BCG-CWS) was prepared as described previously (4 Preparation of oil-treated 6-0-stearoyl-N-acetylmuramyldipeptide. 6-0-stearoyl-N-acetylmuramyldipeptide was placed in a 5-ml tissue grinder. One drop of mineral oil (Drakeol 6VR, Pennsylvania Refining Co., Butler, Pa.) was added, using a syringe with a 26-gauge injection needle, to 4 mg of 6- 0-stearoyl-N-acetylmuramyldipeptide placed in a 5-ml tissue grinder equipped with a Teflon pestle, and the mixture was ground to a smooth paste by rotation at 800 rpm. Then 4 ml of saline solution containing 0.2% Tween 80, which had been kept for 30 min at 60 C, was added to the tube, and grinding was continued for 2 to 3 min to obtain a uniform suspension of small oil droplets containing 6-0-stearoyl-Nacetylmuramyldipeptide at a concentration of 1 mg/ ml. Oil-treated 6-0-stearoyl-N-acetylmuramyldipeptide was sterilized by heating at 60 C for 30 min.
Determination of antibacterial a-amylase antibody titer in sera. This was carried out by the method of Okada et al. (23) .
Tissue culture. The in vitro culture technique described by Marbrook (19) was used. Briefly, 1 ml of cell suspension containing 2 x 107 nucleated cells in RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum plus 100 gg of streptomycin and 100 U of penicillin per ml in a glass tube (15 by 80 mm) covered with dialysis membrane at the top was placed in a bottle (30 by 70 mm) and incubated at 37 C in a humidifed CO2 incubator with a gas flow of 10% CO2 and 90% air. After 4 days of incubation, cells were harvested and a hemolytic plaque assay was done. Plaque-forming cells (PFC) against SRBC were assayed as described previously (15, 28 (9) with slight modifications. One milliliter of a 3'Cr-labeled target cell suspension (1 x 105/ml) mixed with an equal volume of effector cell suspension (1 x 107) was incubated at 37 C for 20 h in a humidified CO2 incubator. All assays were set up in duplicate or triplicate. The ratio of effector cells to target cells was 100:1. As a control, target cells, either mixed with nonimmunized spleen cells or alone, were incubated for the same period. At the end of the incubation period, the cells were centrifuged at 1,000 x g for 10 min. One milliliter of supernatant was carefully removed and counted in a well-type gamma radiation counter. Target cell lysis was expressed as percentage of specific target cell lysis according to the following formula:
% of specific target cell lysis = release with effector cells -control release maximal release -control release Maximal chromium release was measured at the time of complete cell lysis, when target cells alone were frozen and thawed two times.
Determination of adjuvant activity on antihapten response to the T-independent antigen DNP-Ficoll in vivo and in vitro. C57Bl/6J mice were immunized intraperitoneally with a PBS solution of DNP26-Ficoll (100 ,.g) and synthetic muramylpeptides (100 pg). One week later, anti-trinitrophenyl (TNP) PFC in spleen cells were assayed. Anti-TNP antibody in sera was determined by passive hemagglutination with TNP SRBC by using microtiter plates (Cooke Engineering Co., Alexandria, Va.). Details of the in vivo and in vitro assay of antihapten antibody were described previously (28) . In the in vitro system, spleen cells (2 x 107) were cultured with 10 ng of DNP26-Ficoll and synthetic muramylpeptides for 4 days by Marbrook's method (19) , and anti-TNP PFC were determined. Determination of mitogenic activity in mouse spleen cells. Spleen cells (2 x 106) of C57B1/6J mice suspended in 1 ml of RPMI 1640 containing 10% fetal calf serum were incubated with synthetic peptide dissolved in PBS or with mitogens for 48 h at 37 C in a humidifed CO2 incubator, and 0.5 ,uCi of [3H]thymidine (The Radiochemical Centre, Amersham, England) was added from 24 h until the end of culture. The spleen cells were collected by centrifugation and washed with PBS and 5% trichloroacetic acid. After dissolution of the cells by the addition of NCS tissue solubilizer (Amersham/Searle, Arlington, Ill.), 10 ml of toluene scintillator {5 g of 2,5-diphenyloxazole and 0.1 g of 1,4-bis[2-(5-phenyloxazolyl)]benzene in 1,000 ml of toluene} was added, and then the incorporation of [3Hlthymidine was counted in a liquid scintillation counter (Nuclear Chicago Mark II).
RESULTS
Adjuvant activity of synthetic peptides on the induction of delayed-type hypersensitivity to ABA-N-acetyltyrosine in guinea pigs. Hartley strain guinea pigs were immunized with 50 gg of ABA-N-acetyltyrosine dissolved in PBS with or without 100 ,ug of synthetic peptides dissolved in PBS in Freund incomplete adjuvant as a water-in-oil emulsion. Two weeks later, a skin test with ABA-BaA was done. Nacetylmuramyltetrapeptide and N-acetylmuramyldipeptide showed adjuvant activity on the induction of delayed-type hypersensitivity to ABA-N-acetyltyrosine in guinea pigs (Table 1) . It has been observed that n-lactyltetrapeptide (or n-lactyldipeptide) is liberated when N-acetylmuramyltetrapeptide was kept at alkaline conditions (higher than pH 11.0) (Kusumoto et al., unpublished data). In this experiment, the adjuvant activity of chemically synthesized '-lactyltetrapeptide and D-lactyldipeptide on the induction of delayed-type hypersensitivity to ABA-N-acetyltyrosine in guinea pigs was also examined. Both D-lactyltetrapeptide and n-lactyldipeptide were inactive as adjuvant in this system even at a dose of 500 ,ug (Table 1) . To confirm this result, the adjuvant activity of tetrapeptide, N-acetylmuramyldipeptide, and 6-0 -stearoyl-N-acetylmuramyldipeptide was examined at various doses in guinea pigs. Nacetylmuramyldipeptide showed potent adjuvant activity on the induction of delayed hypersensitivity to ABA-N-acetyltyrosine at doses of 1, 10, and 100 ,ug per guinea pig (Table 2) . On the other hand, 6-0-stearoyl-N-acetylmuramyldipeptide showed clear adjuvant activity only at a dose of 100 ug. The delayed-type skin reaction to ABA-N-acetyltyrosine was not clear in guinea pigs when 10 or 1 ,ug of 6-0-stearoyl-N-acetylmuramyldipeptide was used as adjuvant in this study. Tetrapeptide did not have Adjuvant activity of synthetic peptides on the induction of the circulating antibody to BaA in mice. Saline solutions of the synthetic peptides were mixed with BaA dissolved in saline and emulsified in a water-in-oil form in Freund incomplete adjuvant. Each 0.2 ml of the emulsion was injected intraperitoneally into (C57B1/6J x DBA/2)F, mice and BaA in sera was determined by the method of Okada et al. (23) . All the synthetic compounds tested in this study suppressed circulating-antibody formation to BaA in sera (Table 3) ; however, potent adjuvant activity was observed when a mixture of PBS solution of synthetic N-acetylmuramyldipeptide or 6-0-stearoyl-N-acetylmuramyldipeptide and saline solution of BaA was emulsified in a water-in-oil form in Freund incomplete adjuvant and injected intraperitoneally into mice. Tetrapeptide was inactive as adjuvant for the induction of circulating antibody to BaA in mice (Fig. 2) Adjuvant activity of synthetic N-acetylmuramyldipeptide and 6-O-stearoyl-N-acetylmuramyldipeptide to the thymus-independent antigen DNP-Ficoll in vivo and in vitro. It has been established that DNP-Ficoll is a thymusand macrophage-independent antigen (21). To examine the adjuvant effect of these synthetic muramylpeptides to this antigen in vivo, mice were immunized intraperitoneally with 100 Ag of DNP26-Ficoll and 1,000, 100, or 20 ,ug of synthetic muramylpeptides dissolved in PBS. Seven days later, anti-TNP PFC in spleens and anti-TNP antibody in sera of immunized mice were determined. N-acetylmuramyldipeptide clearly showed adjuvant activity at 1,000 and 100 ,ug, and 6-0-stearoyl-N-acetylmuramyldipeptide showed activity at 1,000, 100, and 20 ,ug (Table 5 ). Table 6 ' Dilution titer of passive hemagglutination by using TNP-SRBC in the pooled sera.
d Numbers in parentheses are stimulation ratios.
antibody production in the DNP26-Ficoll in vitro system (Table 6 ).
Adjuvant activity of synthetic peptides on the generation of cell-mediated cytotoxic effector cells in mice. Mice were immunized intraperitoneally with mastocytoma P815-X2 cells combined with an oil-treated preparation, or with a PBS solution of 6-0-stearoyl-N-acetylmuramyldipeptide, or with oil droplets without adjuvant to mastocytoma cells. Eleven days after immunization, cell-mediated cytotoxicity of mouse spleen cells was determined by using 51Cr-labeled mastocytoma P815-X2 cells as target cells. 6-0-stearoyl-N-acetylmuramyldipeptide showed no adjuvant activity in either group of mice that were immunized with mastocytoma P815-X2 cells and 6-0-stearoyl-N-acetylmuramyldipeptide, either treated with oil droplets or dissolved in PBS (Table 7) . It was also shown thatN-acetylmuramyldipeptide dissolved in PBS showed no adjuvant activity in this system. However, the enhancing effect of N-acetylmuramyldipeptide dissolved in PBS on in vitro sensitization of C57BI/6J mouse spleen cells to alloantigen (mitomycin Ctreated DBA/2 mouse spleen cells) was observed (Table 8) .
Mitogenic activity of synthetic peptides. All the synthetic peptides tested in this study were inactive as mitogen on mouse spleen cel,s (Table 9). DISCUSSION It has been shown that N-acetylmuramyldipeptide, MurNAc-L-Ala-D-isoGln, is the minimum adjuvant-active unit of the bacterial cell wall peptidoglycan in the immune system of guinea pigs (Table 1; 1, 6, 17) . In this paper, we examined the adjuvant and mitogenic activities of synthetic peptides and 6-0-stearoyl-N-acetyl- It is evident that N-acetylmuramyldipeptide and 6-0-stearoyl-N-acetylmuramyldipeptide are adjuvant active when mixed with antigen in Freund incomplete adjuvant as a water-in-oil emulsion, and the fact that the possible degraded products of N-acetylmuramylpeptides, i.e., D-lactyltetrapeptide and D-lactyldipeptide, are inactive as adjuvant suggests that N-acetylmuramic acid residue is very important for the adjuvant activity ofN-acetylmuramyltetrapeptide and N-acetylmuramyldipeptide. However, N-acetylmuramyldipeptide cannot be associated to oil droplets. The 6-0-acyl derivative, 6-0-stearoyl -N-acetylmuramyldipeptide, being soluble both in water and mineral oil, can be used as adjuvant both as a water-in-oil and an oil-in-water emulsion. Both N-acetylmuramyldipeptides and 6-0-stearoyl-N-acetylmuramylpeptide showed potent adjuvant activity on the induction of delayed-type hypersensitivity to ABA-N-acetyl-L-tyrosine in guinea pigs ( Table   TABLE 8 2). It was also shown that the adjuvant activity of N-acetylmuramyldipeptide was not potentiated by 6-0-stearoylation. As shown in Table  3 , all the synthetic peptides that were dissolved in saline solution and mixed with BaA in Freund incomplete adjuvant as a water-in-oil emulsion showed no adjuvant activity and suppressed circulating-antibody formation in mice. However, N-acetylmuramyldipeptide and 6-0-stearoyl-N-acetylmuramyldipeptide, which were dissolved in PBS and mixed with BaA in Freund incomplete adjuvant as a water-in-oil emulsion, clearly showed adjuvant activity on circulating-antibody formation in mice (Fig. 1) . Although the discrepancy in these experiments ( Table 2 and Fig. 1) is not yet resolved, we suggest that the acidity due to the free carboxylic acid of both synthetic muramylpeptides or to the detergent activity of 6-0-stearoyl-N-acetylmuramyldipeptide may affect the protein antigen and then influence the immune response in mice. Tetrapeptide showed no adjuvant activity on the production of circulating antibody to BaA in mice ( Fig. 1) , consistent with the results of Table 1 . Both synthetic muramylpeptides were adjuvant active on the production of 19S PFC to SRBC in an in vitro culture system (Table 4) . Recently, Mosier et al. (21) and Sharon et al. (25) have shown that DNP-Ficoll is the thymusand macrophage-independent antigen in vitro. Previously, we reported that the cell walls prepared from cells of M. bovis BCG, Nocardia rubra, and Corynebacterium diphtheriae PW8 acted as adjuvant on the antibody formation to DNP-Ficoll in mice (T. Taniyama et al., unpublished data). Similarly, the present data indicate that N-acetylmuramyldipeptide is active as adjuvant on the immune response to DNPFicoll in mice in vivo and in vitro. These results suggest that N-acetylmuramyldipeptide acts as adjuvant to T-independent antigen.
More recently, we (2, 27) have shown that the cell-mediated cytotoxicity test using the method of Brunner et al. (9) is one of the most useful systems for screening immunotherapeutic agents in experimental animals and humans. 6-0-stearoyl-N-acetylmuramyldipeptide that was treated with minute oil droplets and suspended in PBS showed no adjuvant activity on the generation of cell-mediated cytotoxic effector cells in the spleen of allogeneic mice in vivo (Table 7) . Similarly, N-acetylmuramyldipeptide dissolved in PBS was also shown to be inactive as adjuvant for the induction of cellmediated cytotoxic effector cells by the immunization with mastocytoma P814-X2 cells in vivo. However, N-acetylmuramyldipeptide showed adjuvant activity on the in vitro sensitization of C57BI/6J mouse spleen cells to alloantigen ( Table 8 ). These results suggest that N-acetylmuramyldipeptide and 6-0-stearoyl-N-acetylmuramyldipeptide are not effective as adjuvant when injected intraperitoneally. Preliminary experiments indicated that both N-acetylmuramyldipeptide and 6-0-stearoyl-N-acetylmuramyldipeptide were not effective for the suppression of tumor growth of EL4 and melanoma B16 in C57BI/6J mice by the method described previously (3, 7) .
These synthetic muramylpeptides were not mitogenic in the normal spleen cells of C57BI/ 6J mice (Table 9) . Recently, Rosenstreich et al. (24) reported that the synthetic glycolipid Npalmitoyl-D-glucosamine, which was heated and sonicated, was mitogenic for mouse B lymphocytes. In their experiment, it was shown that N-palmitoyl-D-glucosamine was mitogenic only after treatment by heating and sonication, and it was also suggested that the physical state, a certain degree of dispersion, of this synthetic glycolipid affected the mitogenic activity. We have reported elsewhere (Azuma et al., in press) that the cell walls, which were water insoluble and polymerized peptidoglycolipid, of mycobacteria, nocardia, corynebacteria, and anaerobic coryneforms were mitogenic in both T and B lymphocytes of mice. However, recent papers (8, 10, 20) have shown that water-soluble adjuvants that consisted of arabinogalactan and mucopeptide (peptidoglycan) were B cell mitogens and acted on macrophages (20) . More recently, Damais et al. (11) have reported that peptidoglycans prepared from Escherichia coli and Bacillus megaterium have potent adjuvant activity on spleen cells of rabbits and of normal or nude mice. They have also shown that the peptidoglycan monomer prepared from E. coli is adjuvant active but not mitogenic. These results suggest that both adjuvant and mitogenic activities exhibited in cell walls are clearly dissociated in the low-molecular-weight peptidoglycans and muramyldipeptides, and higher-molecular-weight substances (or the aggregated form of low-molecularweight substances) may be necessary for mitogenic activity.
As summarized in Table 10 , the results reported in this study suggest that N-acetylmuramyldipeptide can represent only a part of the immunological activity of the cell walls of mycobacteria, nocardia, and corynebacteria (2-4, 7, 22, 28; T. Taniyama, unpublished data), and they also suggest that mycolic acid and arabinogalactan may modify and potentiate immunological activities such as adjuvant, mito- genic, and antitumor activities of the peptidoglycan moiety of the cell walls of mycobacteria, nocardia, and corynebacteria.
